Galapagos

Galapagos company information, Employees & Contact Information

Explore related pages

Galapagos email format Galapagos management contacts

Related company profiles:

We are a biotechnology company with operations in the U.S., Europe and Asia, dedicated to developing transformational medicines for more years of life and quality of life. Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class therapies. With capabilities from lab to patient, including an innovative decentralized cell therapy manufacturing platform, we are committed to challenging the status quo and delivering results for our patients, employees and shareholders.

Company Details

Employees
967
Founded
-
Address
Generaal De Wittelaan L11 A3, Mechelen,belgium 2800,belgium
Phone
+32 15 34 29 00
Email
dp****@****lpg.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
glpg.com
Keywords
biotech, R&D, Medicine discovery, Medicine development, Pharmaceuticals, Drug Development.
HQ
Mechelen, Belgium
Competitors
CellPoint, Genmab, Alfasigma, Batavia Biosciences, Sanofi, GSK, Bristol Myers Squibb, argenx, Novartis, Johnson & Johnson.
Looking for a particular Galapagos employee's phone or email?

Galapagos Questions

News

Galapagos NV - Via Ritzau

Galapagos NV Via Ritzau

Galapagos’ HESPERIA Study Tracks Long-Term Follow-Up for Patients Treated With the Company’s CAR-T Therapies - CGTLive®

Galapagos’ HESPERIA Study Tracks Long-Term Follow-Up for Patients Treated With the Company’s CAR-T Therapies CGTLive®

Galapagos Announces Appointment of Fred Blakeslee as General Counsel - The Manila Times

Galapagos Announces Appointment of Fred Blakeslee as General Counsel The Manila Times

Galapagos Brings Oncology Focus to Central NJ - communitynews.org

Galapagos Brings Oncology Focus to Central NJ communitynews.org

Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business - The Manila Times

Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business The Manila Times

Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312 - ACS Publications

Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312 ACS Publications

BridGene Biosciences Expands Strategic Collaboration with Galapagos to Develop Selective Oral SMARCA2 PROTAC in Precision Oncology - PR Newswire

BridGene Biosciences Expands Strategic Collaboration with Galapagos to Develop Selective Oral SMARCA2 PROTAC in Precision Oncology PR Newswire

Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators - Frontiers

Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators Frontiers

Galapagos NV - Via Ritzau

Galapagos NV Via Ritzau

NecstGen Partners with Galapagos to Advance Decentralised CAR-T Cell Manufacturing in Europe - BioInformant

NecstGen Partners with Galapagos to Advance Decentralised CAR-T Cell Manufacturing in Europe BioInformant

FDA Grants RMAT Designation to Novel CAR T-Cell Therapy for R/R Mantle Cell Lymphoma - OncLive

FDA Grants RMAT Designation to Novel CAR T-Cell Therapy for R/R Mantle Cell Lymphoma OncLive

Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies - GlobeNewswire

Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies GlobeNewswire

Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF - Business Wire

Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF Business Wire

IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases - Science | AAAS

IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases Science | AAAS

Galapagos Cleared by FDA to Bring Trial for CAR-T Therapy GLPG5101 in R/R NHL to US - CGTLive®

Galapagos Cleared by FDA to Bring Trial for CAR-T Therapy GLPG5101 in R/R NHL to US CGTLive®

Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care - PR Newswire

Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care PR Newswire

Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases | Journal of Medicinal Chemistry - ACS Publications

Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases | Journal of Medicinal Chemistry ACS Publications

BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets - PR Newswire

BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets PR Newswire

Galapagos Pauses Enrollment in Multiple Myeloma CAR-T Trial After Parkinsonism Case - CGTLive®

Galapagos Pauses Enrollment in Multiple Myeloma CAR-T Trial After Parkinsonism Case CGTLive®

Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases - ACS Publications

Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases ACS Publications

Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis | Journal of M - ACS Publications

Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis | Journal of M ACS Publications

Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos’ CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area - Business Wire

Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos’ CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area Business Wire

Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial - GlobeNewswire

Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial GlobeNewswire

Large-Scale Modeling of Sparse Protein Kinase Activity Data - ACS Publications

Large-Scale Modeling of Sparse Protein Kinase Activity Data ACS Publications

Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation - The Manila Times

Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation The Manila Times

Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic Diseases - ACS Publications

Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic Diseases ACS Publications

Galapagos Enters Clinical Trials with New Cystic Fibrosis Drug - Labiotech.eu

Galapagos Enters Clinical Trials with New Cystic Fibrosis Drug Labiotech.eu

Krispy Kreme Announces Leadership Changes: Retail’s Waiting On The Sidelines - Stocktwits

Krispy Kreme Announces Leadership Changes: Retail’s Waiting On The Sidelines Stocktwits

From Mobile Phones to Catalysts: E-Waste-Derived Heterogeneous Copper Catalysts for Hydrogenation Reactions - ACS Publications

From Mobile Phones to Catalysts: E-Waste-Derived Heterogeneous Copper Catalysts for Hydrogenation Reactions ACS Publications

DatChat Stock Slumps On Announcing Common Stock Offering At Discount Following Tuesday’s 350%+ Surge: Retail Cries Foul - Stocktwits

DatChat Stock Slumps On Announcing Common Stock Offering At Discount Following Tuesday’s 350%+ Surge: Retail Cries Foul Stocktwits

GLPG Stock Price and Chart — EURONEXT:GLPG - TradingView

GLPG Stock Price and Chart — EURONEXT:GLPG TradingView

Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress - NTB Kommunikasjon

Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress NTB Kommunikasjon

Galapagos reaches agreement to acquire GlaxoSmithKline research centre in Zagreb, Croatia - GSK

Galapagos reaches agreement to acquire GlaxoSmithKline research centre in Zagreb, Croatia GSK

It’s not just part of getting old: 7 common myths about arthritis that really aren’t helpful - chronicle.gi

It’s not just part of getting old: 7 common myths about arthritis that really aren’t helpful chronicle.gi

Companies like Galapagos

Novartis logo - Similar company to Galapagos

Novartis

79.78K
Johnson & Johnson logo - Similar company to Galapagos

Johnson & Johnson

100.89K
Bristol Myers Squibb logo - Similar company to Galapagos

Bristol Myers Squibb

38.47K
Genmab logo - Similar company to Galapagos

Genmab

2.61K
Alfasigma logo - Similar company to Galapagos

Alfasigma

2.52K
Batavia Biosciences logo - Similar company to Galapagos

Batavia Biosciences

148
Sanofi logo - Similar company to Galapagos

Sanofi

88.33K
CellPoint logo - Similar company to Galapagos

Cellpoint

57
GSK logo - Similar company to Galapagos

Gsk

90.45K
argenx logo - Similar company to Galapagos

Argenx

1.90K

Top Galapagos Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant